Worldwide Market Reports added Latest Research Report titled “Remote Patient Monitoring Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis ”to its Large Report database.
The Global Remote Patient Monitoring Devices Market was valued at US$ 754.9 million in 2015 and is projected to expand at a CAGR of 7.1% during the forecast period (2017-2025), as highlighted in a new report published by Coherent Market Insights. Technological developments like the innovative portable monitoring device, rising incidences of unhealthy lifestyle related disorders and the enhancing healthcare infrastructure are expected to be major factors driving growth of the global remote patient monitoring devices market over the foreseeable future.
According to the Stanford Center for Sleep Sciences and Medicine 2017, around 30 million people suffer from sleep deprivation and sleep disorders, also known as sleep apnea. Sleep apnea can even cause serious health consequences by increasing the risk of diabetes, hypertension and heart attack if not diagnosed or treated. The collaboration of Telenor Connexion and French eHealth provider, SRETT, in 2014, provides a connected solution for remote monitoring of patients affected by sleep apnea. SRETT has developed a universal solution T4P for all types of continuous positive airway pressure (CPAP) device. The T4P is the only solution adapted to fit all CPAP devices on the market. The connected T4P collects and analyzes data from the CPAP remotely and in real-time, thereby reducing travel time and hospital visits. The patient data is uploaded automatically to healthcare professionals facilitating personalized and ongoing monitoring of patients' condition.
Request for Sample Copy of Research Report: https://www.worldwidemarketreports.com/sample/187625
According to the World Health Organization 2017, one third of ischemic heart disease is attributed to high cholesterol. The raised cholesterol is estimated to cause 2.6 million deaths (4.5% of total) and 29.7 million disability adjusted life years. The remote patient monitoring device provides easy-to-use and portable system with correct assessment of the cholesterol levels.
Cardiac arrhythmia is a condition characterized by the heart's failure to beat slower or faster than normal. According to the World Health Organization 2013, 33.5 million people or 0.5% of the global population is estimated to have Atrial fibrillation, a major condition leading to cardiac arrhythmia. The remote patient monitoring devices provide real-time remote continuous cardiac arrhythmias detection and monitoring platform, allowing easy diagnostics facilitating early clinical intervention of cardiac arrhythmia among high-risk patients. The innovative devices allows the patients to lead a normal life while being remotely monitored in real-time by ambulatory ECG sensor. For instance, Nihon Kohden introduced the Bedside Monitor, BSM-3500 in 2016, which is designed to meet the needs of ambulatory surgical centers and specialty centers. The device offers advanced patient care which includes real-time mini trends for early detection of vital sign variability during outpatient procedures and is also designed to integrate with electronic medical records systems.
Get Best Discount on Research Report: https://www.worldwidemarketreports.com/discount/187625
Key takeaways of the Remote Patient Monitoring Devices Market:
• The global remote patient monitoring devices market is expected to expand at a CAGR of 7.1% during the forecast period (2017-2025) as there exists a huge demanding market especially in Asia Pacific, Latin America, Middle East and Africa.
• The cardiac monitors dominates the market in the product segment, as these portable devices continually monitor electrical activity of the cardiovascular system while performing daily activities.
• The cardiac arrhythmia dominates the market in the application segment, as the cardiac monitors available for monitoring cardiac arrhythmia are easily usable and largely available in medical healthcare facilities and home care settings
• Hospitals and home care settings are the major end users of remote patient monitoring devices market, as these devices offer reliability and accuracy with periodic measurements of physiological parameters like heart activity, blood pressure, body temperature, pulse rate and other clinical conditions.
• Some of the major players involved in global remote patient monitoring devices market are Abbott Laboratories, GE Healthcare, Omron Healthcare, Medtronic, Nihon Kohden, Smiths Medical, Philips Healthcare, F. Hoffmann-La Roche Ltd. And Kokinklijke Philips N.V. and St. Jude Medical.
**If you have any special requirements, please let us know and we will offer you the report as you want.
About WMR
Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.
Contact Us:
Mr. Shah
Worldwide Market Reports
1001 4th Ave,
#3200
Seattle, WA 98154,
U.S
Tel: +1 415 871 0703
Worldwide Market Reports added Latest Research Report titled “Ocular Surgery Market - Market Outlook by Applications, Region, Type and Top Key Players 2017-2025 ”to its Large Report database.
The Global Ocular Surgery Market, by device type (Cataract surgery devices, Glaucoma surgery devices, and Vitrectomy surgery devices) and region was valued at US$ 1,517.5 million in 2017 and is projected to exhibit a CAGR of 7.2% over the forecast period (2017-2025), as highlighted in a new report published by Coherent Market Insights. Growing aging population and high incidence rate of diabetes coupled with technological advancement are drivers fueling growth of the ocular surgery market.
Rise in number of cataract and glaucoma surgeries provide lucrative opportunities for growth of the global ocular surgery market. Increasing aging population globally is expected to fuel growth of the ocular surgery market. According to World Health Organization (WHO), in 2010, around 285 million people were recorded to be suffering from visual impairment, which included 39 million blind people, of which 80% were 50 years of age and above. Cataract surgery segment is expected to grow at a rapid rate, which in turn, is expected to favor growth of the ocular surgery market in near future. High occurrence rate of diabetes, exposure to ultraviolet sunlight, and family medical history are some of the various factors expected to boost growth of the global market. According to the International Diabetes Federation, in 2010, around 285 million people were affected by diabetes mellitus, which signifies a high risk of glaucoma and cataract among these people.
Request for Sample Copy of Research Report: https://www.worldwidemarketreports.com/sample/202066
Browse 50 Market Data Tables and 25 Figures spread through 170 Pages and an in-depth TOC on ‘Ocular Surgery Market by Procedure (Cataract surgery, Glaucoma surgery, and Vitrectomy), Device type (Cataract surgery devices, Glaucoma surgery devices, and Vitrectomy surgery devices) and Region - Global Forecast to 2025'
Development of technologically advanced ocular devices, including femtosecond laser cataract surgery technology and intraocular lenses (IOLs), such as Toric IOLs, reduce dependency on glasses or contact lenses post-surgery. In 2016, Allergan received FDA-clearance for the XEN Gel Stent, a new surgical treatment that reduces intraocular pressure for patients with refractory glaucoma. Xen Gel stent is an effective alternative to conventional surgeries such as Trabeculectomy. Technological advancements are thus, creating less painful and time-efficient procedures, which in turn, is improving surgery outcomes in an effective, safe, and predictable manner.
Get Best Discount on Research Report: https://www.worldwidemarketreports.com/discount/202066
Asia Pacific and Africa are expected to witness maximum growth in the global ocular surgery market, owing to rapid increase in aging population in these region. According to NCBI, 2010, around 11.2 million people 40 years of age and above suffered from glaucoma, in India; while in Australia, in 2016, around 1 in 30 people were hospitalized due to eye-related problems.
According to American Academy of Ophthalmology, in 2015, Africa was highly affected by glaucoma, with the highest prevalence of Primary Open Angle Glaucoma (POAG) in African countries and is expected to experience meteoric growth over the forecast period.
Key takeaways of the market:
• The global ocular surgery market is expected to exhibit a CAGR of 7.2% over the forecast period (2017-2025), due rampant growth in precursor diseases such as diabetes
• Among device types, the cataract surgery devices segment holds a dominant position, as cataracts remain the leading cause of blindness. According to World Health Organization (WHO), in 2014, 47.8% of blindness, globally, was caused by cataracts.
• Some of the major players involved in global ocular surgery market are Johnson & Johnson Vision Care Inc., Alcon, Carl Zeiss, Meditec, Bausch & Lomb, Ellex Medical Lasers, Topcon Medical Systems, Dutch Ophthalmic Research Center (International) B.V. (DORC), and Lumenis.
**If you have any special requirements, please let us know and we will offer you the report as you want.
About WMR
Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.
Contact Us:
Mr. Shah
Worldwide Market Reports
1001 4th Ave,
#3200
Seattle, WA 98154,
U.S
Tel: +1 415 871 0703
Worldwide Market Reports added Latest Research Report titled “Opioids Market - by Drug Class, Antagonist, Trends, Therapeutic Application, and by Geography Till 2025 ”to its Large Report database.
Global Opioids Market, by Drug Class (Agonist (Codeine, Fentanyl, Meperidine, Methadone, Morphine, Hydrocodone, Diphenoxylate, Hydromorphone, Methylphenidate, Oxycodone, Oxymorphone) and Antagonist (Buprenorphine, Naloxone, Naltrexone, Methylnaltrexone, Nalbuphine)), by Therapeutic Application (Pain Management, Cough Treatment, Diarrhea Treatment), and by Geography (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa) was valued at US$ 28,252.3 million in 2016 and is expected to witness a CAGR of 5.3% over the forecast period (2017 - 2025), as highlighted in a new report published by Coherent Market Insights. Increasing incidences of chronic pain, easy accessibility to opioids, especially in developed economies, and low cost of opioids as compared to alternative pain therapy are the prime forces driving growth of this market. However, increasing intervention from government or regulatory bodies and growing adoption of cannabis may hinder the growth of the market.
Request for Sample Copy of Research Report: https://www.worldwidemarketreports.com/sample/202397
In October 2017, the U.S. president Donald Trump declared the opioid crisis as a public health emergency. This declaration will be helpful in increasing the awareness about the drug overuse or abuse and also, restrict the doctors from over-prescribing the opioids drug. However, the government denied any financial assistance.
The New York State Attorney General's office sent letters to three largest pharmacy benefit managers in the U.S. — CVS Caremark, Express Scripts, and OptumRx respectively, in September 2017, asking them to provide information on the steps they are undertaking to address the opioid crisis. Moreover, during the same month, Attorney General of over 35 states in the U.S. sent a letter to the health insurance industry's main trade group, recommending its members to reconsider coverage policies that may be fueling the opioid crisis.
Browse 130 Market Data Tables and 42 Figures spread through 313 Pages and in-depth TOC on Opioids Market, by Drug Class (Agonist (Codeine, Fentanyl, Meperidine, Methadone, Morphine, Hydrocodone, Diphenoxylate, Hydromorphone, Methylphenidate, Oxycodone, Oxymorphone) and Antagonist (Buprenorphine, Naloxone, Naltrexone, Methylnaltrexone, Nalbuphine)), by Therapeutic Application (Pain Management, Cough Treatment, Diarrhea Treatment), and by Geography (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa) - Global Forecast to 2024
Get Best Discount on Research Report: https://www.worldwidemarketreports.com/discount/202397
The regulatory authorities in U.S. started taking steps towards combating the issue by encouraging the use of opioid antagonists as prescription opioids for adults and children, given the changing scenario of opioid prescription for medication to misuse and overuse of the drug leading to opioid crisis. For instance, the Commissioner's Opioid Action Plan by U.S. FDA in 2016 addressed the epidemic of opioid abuse, addiction and overdose wherein, the FDA approved two products of naloxone for the community use in adults and pediatrics. On the other hand, the FDA made the regulatory guidelines more stringent pertaining to prescription opioids (agonists), for both medical practitioners and healthcare providers as well as for prescription opioids manufacturers.
According to a study conducted by RTI International, the lifetime rate of nonmedical opioid use in the European Union was close to 14% in 2016, significantly high from the previous year in which it was computed to be around 5%. Moreover, according to The European Drug Situation in 2017 report, opioids overdose resulted in 81% of all deaths due to drug overdose in European countries in 2016.
European Monitoring Centre for Drugs and Drugs Addiction has warned against the opioid overuse in 2017. Moreover, The European Drug Report 2017 states that five countries (Germany, Spain, France, Italy, and UK) accounted for 76% of the high-risk opioid users in the European Union. Opioid abuse has been a major factor for its higher sales and addiction. Nearly 38% of the treatment requests in European Union included opioid as the principal drugs (The European Drug Report 2017). However, government in respective countries are taking steps to promote opioid antagonists use which are safer compared to the opioid agonist drugs.
Key Takeaways of the Opioids Market:
• The global opioids market is expected to exhibit a CAGR of 3% over the forecast period (2016 - 2024), owing to increasing incidence of chronic pain, especially in developed countries
• Opioids overuse or abuse, which is contributing significantly to this market expansion, has become a major concern in developed regions such as North America
• Alternative drugs for pain management such as cannabis, have gained attraction over the recent past. If proven effective and safe, cannabis is expected to potential to replace opioids
• The use of medical cannabis has been endorsed by numerous professional organizations in the U.S., including the American Academy of Family Physicians, the American Public Health Association, and the American Nurses Association. In other developed countries such as UK, Germany, and other European countries, cannabis has gained significant traction, however it is yet to receive endorsements
• Pressure is mounting on leading pharmacy chains such as CVS, to assist in limiting the opioid drug prescription
• Key companies covered in this study include Purdue Pharma L.P., Titan Pharmaceuticals, Inc., Boehringer Ingelheim GmbH, Janssen Pharmaceuticals, Inc., Sanofi S.A., Sun Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Egalet Corporation, Endo Pharmaceuticals Inc., Allergan, Plc, and Pfizer Inc.
**If you have any special requirements, please let us know and we will offer you the report as you want.
About WMR
Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.
Contact Us:
Mr. Shah
Worldwide Market Reports
1001 4th Ave,
#3200
Seattle, WA 98154,
U.S
Tel: +1 415 871 0703
Worldwide Market Reports added Latest Research Report titled “Digital Wound Management Devices Market - Industry Insights, Size, Share, Opportunity Analysis, and Industry Forecast till 2025 ”to its Large Report database.
The Global Digital Wound Management Devices Market was valued at US$ 3.3 million in 2016 and is projected to expand at a CAGR of 6.8% during the forecast period (2017-2025), as highlighted in a new report published by Coherent Market Insights. Technological advancements by key players, increasing healthcare expenditure by governments, and rising prevalence of diabetic population attributed to having a meteoric growth of the digital wound management devices market over the forecast period.
Rise in ulcer cases and chronic wound cases provide a lucrative growth of the global digital wound management devices market. Any wound that does not heal in the span of 6 weeks is considered as a chronic wound. The increase in chronic wound cases globally, expected to fuel the growth of digital wound management devices market. In 2015, According to Healogics Inc., around 6.7 million people in the U.S. were suffering from non-healing advanced wounds and this number is expected to grow at more than 2% over the following decade. Furthermore, every year around 2.5 million people aged over 75 years acquires a pressure ulcer, which is approximately 13.2% of the total population in 2015. Thereby, contributing to growth of global digital wound management devices that are extremely useful to decrease doctor's facility re-affirmation and achieve a positive clinical result.
Request for Sample Copy of Research Report: https://www.worldwidemarketreports.com/sample/202042
The rise in number of diabetic population and aging population are the supportive factors propelling the growth of chronic wound cases around the globe. According to the Centers for Disease Control and Prevention (CDC), in 2014, around 29.1 million people in U.S. were suffering from diabetes, which contributed to around 9.3% of the total population. Furthermore, the diabetes mellitus contributes to 90-95% cases of the total diabetic population. The key developments in the digital wound management devices enable real-time bacterial imaging in wounds at the point-of-care for efficient wound assessment and monitoring.
Developed economies such as the U.S., Japan, and Australia are characterized by high capital investment on introducing advanced technologies, especially in the healthcare sector. Biochemical assessment of the wound appears to be a rational approach to treatment selection and monitoring. However, it is not yet standardized or validated and the cost associated with the treatment is high. As an alternative, wound morphometric analysis, which refers to using digital wound images may be an effective means of evaluating how the wound responds to the treatment. This allows for a dynamic approach, where wound treatments can be evaluated and subsequently changed if the wound-healing response is negligible. A technology shift has been observed in the global healthcare sector, with manufacturers focusing on highly accurate monitoring operational devices that can ease the device development work and improve efficiency at the same time. For instance, the collaboration of Fuel3D with FittingBox, which is world leader in virtual try-on solutions for eyewear, will develop 3D scanning enhancement for the OWIZ system developed by Fuel3D
Get Best Discount on Research Report: https://www.worldwidemarketreports.com/discount/202042
Key takeaways of the Ambulatory Blood Pressure Monitors Market:
• The global digital wound management devices market is expected to expand at a CAGR of 6.8% during the forecast period (2017-2025) as there exists a huge demanding market especially in Asia Pacific, Latin America, the Middle East, and Africa.
• The diabetic ulcer digital wound management devices dominates the market in the product segment, as it is easily usable and largely available, and it promote a moist wound healing environment.
• Hospitals and Ambulatory Surgical Centers are the major end-users of digital wound management devices market owing to easy accessibility of these devices.
• Some of the major players involved in global digital wound management devices market are WoundMatrix, Aranz Medical Ltd., Woundzoom Inc., Woundvision, LLC., Tissue Analytics, Inc., Parable Health, Inc., and Rubitection, Inc
**If you have any special requirements, please let us know and we will offer you the report as you want.
About WMR
Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.
Contact Us:
Mr. Shah
Worldwide Market Reports
1001 4th Ave,
#3200
Seattle, WA 98154,
U.S
Tel: +1 415 871 0703
Worldwide Market Reports added Latest Research Report titled “Remote Patient Monitoring Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis ”to its Large Report database.
The Global Remote Patient Monitoring Devices Market was valued at US$ 754.9 million in 2015 and is projected to expand at a CAGR of 7.1% during the forecast period (2017-2025), as highlighted in a new report published by Coherent Market Insights. Technological developments like the innovative portable monitoring device, rising incidences of unhealthy lifestyle related disorders and the enhancing healthcare infrastructure are expected to be major factors driving growth of the global remote patient monitoring devices market over the foreseeable future.
According to the Stanford Center for Sleep Sciences and Medicine 2017, around 30 million people suffer from sleep deprivation and sleep disorders, also known as sleep apnea. Sleep apnea can even cause serious health consequences by increasing the risk of diabetes, hypertension and heart attack if not diagnosed or treated. The collaboration of Telenor Connexion and French eHealth provider, SRETT, in 2014, provides a connected solution for remote monitoring of patients affected by sleep apnea. SRETT has developed a universal solution T4P for all types of continuous positive airway pressure (CPAP) device. The T4P is the only solution adapted to fit all CPAP devices on the market. The connected T4P collects and analyzes data from the CPAP remotely and in real-time, thereby reducing travel time and hospital visits. The patient data is uploaded automatically to healthcare professionals facilitating personalized and ongoing monitoring of patients' condition.
Request for Sample Copy of Research Report: https://www.worldwidemarketreports.com/sample/187625
According to the World Health Organization 2017, one third of ischemic heart disease is attributed to high cholesterol. The raised cholesterol is estimated to cause 2.6 million deaths (4.5% of total) and 29.7 million disability adjusted life years. The remote patient monitoring device provides easy-to-use and portable system with correct assessment of the cholesterol levels.
Cardiac arrhythmia is a condition characterized by the heart's failure to beat slower or faster than normal. According to the World Health Organization 2013, 33.5 million people or 0.5% of the global population is estimated to have Atrial fibrillation, a major condition leading to cardiac arrhythmia. The remote patient monitoring devices provide real-time remote continuous cardiac arrhythmias detection and monitoring platform, allowing easy diagnostics facilitating early clinical intervention of cardiac arrhythmia among high-risk patients. The innovative devices allows the patients to lead a normal life while being remotely monitored in real-time by ambulatory ECG sensor. For instance, Nihon Kohden introduced the Bedside Monitor, BSM-3500 in 2016, which is designed to meet the needs of ambulatory surgical centers and specialty centers. The device offers advanced patient care which includes real-time mini trends for early detection of vital sign variability during outpatient procedures and is also designed to integrate with electronic medical records systems.
Get Best Discount on Research Report: https://www.worldwidemarketreports.com/discount/187625
Key takeaways of the Remote Patient Monitoring Devices Market:
• The global remote patient monitoring devices market is expected to expand at a CAGR of 7.1% during the forecast period (2017-2025) as there exists a huge demanding market especially in Asia Pacific, Latin America, Middle East and Africa.
• The cardiac monitors dominates the market in the product segment, as these portable devices continually monitor electrical activity of the cardiovascular system while performing daily activities.
• The cardiac arrhythmia dominates the market in the application segment, as the cardiac monitors available for monitoring cardiac arrhythmia are easily usable and largely available in medical healthcare facilities and home care settings
• Hospitals and home care settings are the major end users of remote patient monitoring devices market, as these devices offer reliability and accuracy with periodic measurements of physiological parameters like heart activity, blood pressure, body temperature, pulse rate and other clinical conditions.
• Some of the major players involved in global remote patient monitoring devices market are Abbott Laboratories, GE Healthcare, Omron Healthcare, Medtronic, Nihon Kohden, Smiths Medical, Philips Healthcare, F. Hoffmann-La Roche Ltd. And Kokinklijke Philips N.V. and St. Jude Medical.
**If you have any special requirements, please let us know and we will offer you the report as you want.
About WMR
Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.
Contact Us:
Mr. Shah
Worldwide Market Reports
1001 4th Ave,
#3200
Seattle, WA 98154,
U.S
Tel: +1 415 871 0703
Worldwide Market Reports added Latest Research Report titled “Needle-free IV Connectors Market - Industry Insights, Market Segmentation, Opportunities, Trends & Future Scope Till 2025 ”to its Large Report database.
The Global Needle-free IV Connectors Market by design (simple and complex), mechanism (positive, negative, and neutral), dwell time (seven-day and other than seven-day) and region (North America, Latin America, Europe, Asia-Pacific, the Middle East, and Africa) was valued at US$ 621.1 million in 2016 and is projected to exhibit a CAGR of 10.3% over the forecast period (2017-2025), as highlighted in a new report published by Coherent Market Insights. Growing prevalence of chronic diseases with need of treatment for the same, the risk of possible bloodstream infections and effectiveness over conventional IV administration are expected to be the major factors driving the growth of the global needle-free IV connectors market over the forecast period.
Manufacturers are focusing on minimizing the risks associated with IV administration with conventional methods as well as any existing minor issues associated with the use of needle-free IV connectors namely blood reflux caused by gasket compression and blood reflux due to disconnection. For instance, MicroClave connector from ICU Medical provides minimal blood reflux in the catheter tip. The company has received three type of the U.S. patents for MicroClave clear needle-free connector in 2015 and 2016. RyMed Technologies developed InVision-Plus with the neutral advantage technology designed to reduce the bacterial contamination. Furthermore, Nexus Medicals has designed a next generation infusion therapy technology, Nexus TKO to solve infection and occlusion issues.
Browse 70 Market Data Tables and 30 Figures spread through 200 Pages and in-depth TOC on "" Needle-Free IV Connectors Market by Design (simple and complex), Mechanism (positive, negative, and neutral), Dwell Time (seven-day and other than seven-day) and Region (North America, Latin America, Europe, Asia-Pacific, the Middle East, and Africa) - Global Forecast to 2025
Request for Sample Copy of Research Report: https://www.worldwidemarketreports.com/sample/202046
Manufacturers are working on developing and providing connectors for intravenous as well as for other routes of administration. ICU Medical's Tego needle-free connector is world's first Food and Drug Administration (FDA) approved in hemodialysis applications. Furthermore, in 2016, Vygon S.A. launched Nutrifit enteral connectors, which are used for neonates and newborns for safe and secure enteral feeding. The companies have resorted to mergers and acquisitions in the past few years to make use of the innovative IV administration technologies present in the market along with increasing their own product portfolio in order to create a strong presence in the intravenous therapies market, which is expected to propel the market growth over the forecasted period. In 2017, ICU Medical completed acquisition of Hospira Infusion Systems from Pfizer Inc., in 2014 Becton, Dickinson and Company acquired CareFusion Corporation and Medtronic Plc acquired Covidien
Get Best Discount on Research Report: https://www.worldwidemarketreports.com/discount/202046
Key Takeaways of the Needle-Free IV Connectors Market:
• The global needle-free IV connectors market is expected to exhibit a CAGR of 3% over the forecast period (2016-2025), owing to the presence of high potential markets, especially in Asia Pacific, Latin America, the Middle East, and Africa
• Robust developments in connector designs, mergers and acquisitions, and inclusion of novel connector technologies in the market are expected to drive the global needle-free IV connectors market.
• Some major players operating in the needle-free IV connectors market are Baxter International Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, CareFusion Corporation, ICU Medical, Inc., Nexus Medical LLC, RyMed Technologies, LLC, and Vygon SA.
**If you have any special requirements, please let us know and we will offer you the report as you want.
About WMR
Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.
Contact Us:
Mr. Shah
Worldwide Market Reports
1001 4th Ave,
#3200
Seattle, WA 98154,
U.S
Tel: +1 415 871 0703
Worldwide Market Reports added Latest Research Report titled “Remote Patient Monitoring Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis”to its Large Report database.
The Global Remote Patient Monitoring Devices Market was valued at US$ 754.9 million in 2015 and is projected to expand at a CAGR of 7.1% during the forecast period (2017-2025), as highlighted in a new report published by Coherent Market Insights. Technological developments like the innovative portable monitoring device, rising incidences of unhealthy lifestyle related disorders and the enhancing healthcare infrastructure are expected to be major factors driving growth of the global remote patient monitoring devices market over the foreseeable future.
According to the Stanford Center for Sleep Sciences and Medicine 2017, around 30 million people suffer from sleep deprivation and sleep disorders, also known as sleep apnea. Sleep apnea can even cause serious health consequences by increasing the risk of diabetes, hypertension and heart attack if not diagnosed or treated. The collaboration of Telenor Connexion and French eHealth provider, SRETT, in 2014, provides a connected solution for remote monitoring of patients affected by sleep apnea. SRETT has developed a universal solution T4P for all types of continuous positive airway pressure (CPAP) device. The T4P is the only solution adapted to fit all CPAP devices on the market. The connected T4P collects and analyzes data from the CPAP remotely and in real-time, thereby reducing travel time and hospital visits. The patient data is uploaded automatically to healthcare professionals facilitating personalized and ongoing monitoring of patients' condition.
Request for Sample Copy of Research Report: https://www.worldwidemarketreports.com/sample/187625
According to the World Health Organization 2017, one third of ischemic heart disease is attributed to high cholesterol. The raised cholesterol is estimated to cause 2.6 million deaths (4.5% of total) and 29.7 million disability adjusted life years. The remote patient monitoring device provides easy-to-use and portable system with correct assessment of the cholesterol levels.
Cardiac arrhythmia is a condition characterized by the heart's failure to beat slower or faster than normal. According to the World Health Organization 2013, 33.5 million people or 0.5% of the global population is estimated to have Atrial fibrillation, a major condition leading to cardiac arrhythmia. The remote patient monitoring devices provide real-time remote continuous cardiac arrhythmias detection and monitoring platform, allowing easy diagnostics facilitating early clinical intervention of cardiac arrhythmia among high-risk patients. The innovative devices allows the patients to lead a normal life while being remotely monitored in real-time by ambulatory ECG sensor. For instance, Nihon Kohden introduced the Bedside Monitor, BSM-3500 in 2016, which is designed to meet the needs of ambulatory surgical centers and specialty centers. The device offers advanced patient care which includes real-time mini trends for early detection of vital sign variability during outpatient procedures and is also designed to integrate with electronic medical records system.
Get Best Discount on Research Report: https://www.worldwidemarketreports.com/discount/187625
Key takeaways of the Remote Patient Monitoring Devices Market:
• The global remote patient monitoring devices market is expected to expand at a CAGR of 7.1% during the forecast period (2017-2025) as there exists a huge demanding market especially in Asia Pacific, Latin America, Middle East and Africa.
• The cardiac monitors dominates the market in the product segment, as these portable devices continually monitor electrical activity of the cardiovascular system while performing daily activities.
• The cardiac arrhythmia dominates the market in the application segment, as the cardiac monitors available for monitoring cardiac arrhythmia are easily usable and largely available in medical healthcare facilities and home care settings
• Hospitals and home care settings are the major end users of remote patient monitoring devices market, as these devices offer reliability and accuracy with periodic measurements of physiological parameters like heart activity, blood pressure, body temperature, pulse rate and other clinical conditions.
• Some of the major players involved in global remote patient monitoring devices market are Abbott Laboratories, GE Healthcare, Omron Healthcare, Medtronic, Nihon Kohden, Smiths Medical, Philips Healthcare, F. Hoffmann-La Roche Ltd. And Kokinklijke Philips N.V. and St. Jude Medical.
**If you have any special requirements, please let us know and we will offer you the report as you want.
About WMR
Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.
Contact Us:
Mr. Shah
Worldwide Market Reports
1001 4th Ave,
#3200
Seattle, WA 98154,
llU.S
Tel: +1 415 871 0703
Worldwide Market Reports added Latest Research Report titled “Drug Eluting Stents Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis”to its Large Report database.
The Global Drug Eluting Stents Market was valued at US$ 5912.9 million in 2016 and is projected to expand at a CAGR of 4.7% during the forecast period (2017-2025), as highlighted in a new report published by Coherent Market Insights. Increase in geriatric population in turn is projected to support growth of drug eluting stents market over the forecast period.
Drug eluting stents are small expandable tubes made of wire that are inserted into the coronary arteries of patients with atherosclerosis. Stent helps to hold the artery open to release a drug that prevents blockage occurring in artery and improves the blood flow. This stent placement are generally carried out in the procedure of coronary angioplasty.
The constantly rise in geriatric population drives the growth of the market as the population is at a high risk of developing arterial diseases. In addition unhealthy dietary habits, sedentary lifestyles and lack of exercise are some of the factors resulting in the increased prevalence of artery diseases. As a result he demand for drug eluting stents is escalating as artery diseases is widely treated by using drug eluting stents. However the decrease in price of this device is enhancing the market growth. Hence this factors are expected to challenge the growth of the market in the forecast period.
Request for Sample Copy of Research Report: https://www.worldwidemarketreports.com/sample/187621
According to the National Institute on Aging the world's geriatric population in 2015 was around 8.5% and it may rise around 17% by 2050. Hence the minimally-invasive techniques of DES placing is expected to enhance the growth of drug eluting stent market.
The drug eluting stents are used for the treatment of artery diseases as a result this application is expected to maintain its dominance throughout the future near. As per the stats published in 2015 by The Heart Foundation, coronary artery disease causes around 380,000 deaths yearly in the U.S. Furthermore, around 720,000 people suffer from heart attacks each year and among these around 205,000 are cases of heart attack. As per the World Health Organization (WHO) it was estimated around 17.7 million people died from cardiovascular diseases (CVDs) in 2015, representing 31% of all global deaths. Among this deaths, an estimated 7.4 million were due to coronary heart disease and 6.7 million were due to stroke. Furthermore around 2% of death is occurred due to rheumatic heart disease.
Get Best Discount on Research Report: https://www.worldwidemarketreports.com/discount/187621
Key takeaways of the market:
• The global drug eluting stents market is expected to expand at a CAGR of 4.7% during the forecast period (2017-2025). Due to rising number of geriatric population and increase in cardiovascular disease cases from around the globe is expected to favor the market of drug eluting stents over the forecast period.
• The North America region in the global drug eluting stents market is expected to show high growth rate followed by Asia Pacific during the forecast period in terms of value
• In terms of product segment, the polymer based coatings type was valued at US$ 5337.4 Mn in 2016 and is expected to reach US$ 8174.3 Mn by 2025 at a CAGR of 4.8%
• The increase in adoption of biodegradable stents is expected to drive the growth of the polymer based coating stents segment.
• In terms of application the coronary artery diseases type was valued at US$ 4117.0 Mn in 2016 and is expected to reach US$ 6334.9 Mn by 2025 at a CAGR of 4.9%
• Drug eluting stents are considered as gold standard for the treatment of coronary artery disease. As a result, this application segment is expected to maintain its dominance in the forecast period.
The major key players of drug eluting stents market are Boston Scientific Corporation, Medtronic, Inc., Abbott Laboratories, Biosensors International Group, Biotronik, Lepu Medical Technology, Terumo Medical Corporation, Cook Medical, Shandong JW Medical Systems, Stentys, Abbott Vascular Inc., AlviMedica Medical Technologies Inc., Amaranth Medical, Inc., HangZhou HuaAn Biotechnology Co.,Ltd, XTENT, Inc., CARDIONOVUM GmbH, Cordis Corporation KYOTO MEDICAL PLANNING Co., Ltd.
**If you have any special requirements, please let us know and we will offer you the report as you want.
About WMR
Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.
Contact Us:
Mr. Shah
Worldwide Market Reports
1001 4th Ave,
#3200
Seattle, WA 98154,
llU.S
Tel: +1 415 871 0703
Worldwide Market Reports added Latest Research Report titled “Generic Sterile Injectable Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis”to its Large Report database.
The Global Generic Sterile Injectable Market was valued at US$ 42,900 million in 2015 and is projected to expand at a CAGR of 10.2% during the forecast period (2017-2025), as highlighted in a new report published by Coherent Market Insights. The consistency in the shortage of critical medications that mainly consists of generic sterile injectable having no substitutes is expected to be major factor driving growth of the global generic sterile injectable market over the foreseeable future.
Each year, an estimated 50 million people suffer from bone chronic diseases such as Cancer, heart attack, heart stroke, diabetes and other respiratory diseases. These disease are one of the leading cause of mortality in the world accounting up to 60% of worldwide deaths according to WHO. Thanks to the availability of generic sterile injectable that are used to treat these chronic diseases with the help of which, a substantial number of people who suffer from such diseases are saved due to proper medication.
Request for Sample Copy of Research Report: https://www.worldwidemarketreports.com/sample/187617
The generic sterile injectable are used for the treatment of life threatening diseases such as cardiovascular diseases, cancer and several other serious infections. These drugs are heavily in bulk demand on a constant basis due to the cost efficiency of these injectable. The generic sterile injectable bears almost 90% less cost as compared to that of the branded sterile injectable drugs. However, the ANDA filing application procedure and the process of manufacturing the generic sterile injectable in as stringent as that of the branded drugs. According to a fact sheet released by Hospira in 2013, about 70% of the hospitals in patients receives generic sterile injectable suggesting high demands.
According to WHO, the chronic diseases are the reason for more than 50% deaths worldwide, in 2015, and these diseases mainly includes cardiovascular diseases, type 2 diabetes, chronic respiratory diseases and cancer. These diseases results from living habits such as physical inactivity, poor diet as well as consumption of tobacco and alcohol. The chronic diseases has severe negative impact on health and economy of developing as well as developed countries. According to a scientific report published in Science literature, around 3 million deaths are caused due to cardiovascular diseases annually in China and India. Moreover, around 1.7 million people die due to tobacco consumption leading to cancer in China and India on an annual basis. According to WHO, 30% of these chronic diseases, mainly cancer are curable and can be treated with appropriate medication. Generic sterile injectable play a major role in treatment of such diseases. Moreover, not only the chronic diseases but it used for the treatment of damages to the central nervous system, infectious disorders and musculoskeletal diseases. Musculoskeletal is a condition that covers a huge segment of conditions such as rheumatoid arthritis, osteoarthritis, and osteoporosis and is characterized by cartilage joint damage that results in severe pain and mobility in the knees and hip joints. According to the WHO and United Nations, osteoarthritis is one of the most commonly caused musculoskeletal disorder affecting 9.6% males and 18% females age group of 60 and above, globally. In case of the infectious diseases, "Statista"- The Statistical Portal for 2014, suggests approximately 48,237,390 cases of malaria as well as 5,730,798 cases of tuberculosis worldwide. This creates highly lucrative growth opportunities for players in the global generic sterile injectable market.
Get Best Discount on Research Report: https://www.worldwidemarketreports.com/discount/187617
Key takeaways of the generic sterile injectable market:
• The global generic sterile injectable market is expected to expand at a CAGR of 10.2% during the forecast period (2015-2025) as there exists a huge unrealized market especially in Asia Pacific, Latin America, Middle East and Africa
• The constant shortage of availability and the high affordability of the generic sterile injectable, mostly for the treatment of chronic diseases drives the global generic sterile injectable market.
• Cancer, diabetes type 2, cardiovascular diseases and other infectious diseases including tuberculosis and malaria are the major therapeutic applications of the generic sterile injectable market as the prevalence of these diseases is high in number, globally.
• Some of the major players involved in global generic sterile injectable market Baxter Inc., Fresenius Kabi, Pfizer/Hospira, Novartis/Sandoz, Teva, Hikma, Sun Pharma, Dr. Reddy's, Mylan, AstraZeneca Plc and Merck & Co. Inc
**If you have any special requirements, please let us know and we will offer you the report as you want.
About WMR
Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.
Contact Us:
Mr. Shah
Worldwide Market Reports
1001 4th Ave,
#3200
Seattle, WA 98154,
llU.S
Tel: +1 415 871 0703
Worldwide Market Reports added Latest Research Report titled “Arthroscopy Devices Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis”to its Large Report database.
The Global Arthroscopy Devices Market was valued at US$ 3,910.7 million in 2016 and is projected to expand at a CAGR of 5.4% during the forecast period (2017-2025), as highlighted in a new report published by Coherent Market Insights. Increasing number of knee implantation and hip implantation procedure is supporting growth of the arthroscopy devices market.
Arthroscopy being a minimally invasive surgery, significantly reduces patient recovery time, decreases chances of infection during surgical procedure, and curtails bleeding during surgery. Being a largely outpatient surgical procedure, the patient needs to stay in the hospital for just a few days, with the procedure itself lasting for a few hours. Therefore, the preference for arthroscopic procedures is increasing instead of general/open surgical procedure. Furthermore, wide adoption of technologically advanced implants such as cementless prosthetics are also supporting growth in number of people opting for such implantations. The other factors related to the growth of implantation are alarming increase in rate of road accidents and growing obese population worldwide leading to the growth of knee pain, fractures and osteoarthritis which also known as degenerative joint disease.
Request for Sample Copy of Research Report: https://www.worldwidemarketreports.com/sample/187613
As per the stats published by Centers for Disease Control and Prevention, around 54.4 million people in U.S. were suffering from some form of arthritis and rheumatoid arthritis in 2013-2015. This number is expected to increase to around 78 million by 2040. Therefore, it is estimated that this factors will support the growth of arthroscopy devices market in the near future.
Arthritis is a highly prevalent disease, with prevalence rate increasing steadily. For instance, as per data published by Arthritis Foundation, in U.S., arthritis affects 1 in 4 adults and its prevalence increased by 22.7% during 2010-2012. Furthermore, the prevalence of severe joint pain was 27% among adults with arthritis in 2016, with prevalence especially high among people ages 64 years and above.
Also, as per Arthritis Foundation, the number of adults suffering from severe joint pain increased from 10.5 million in 2002 to 14.6 million in 2014, in the U.S.
Get Best Discount on Research Report: https://www.worldwidemarketreports.com/discount/187613
Also, other factors driving growth of arthroscopy devices market is increasing number of arthroscopy procedures due to sport injuries. Athletes and sportspersons are inclined towards opting for arthroscopy surgery for treatment of sports related injuries, as the recovery time associated with it is relatively less. As per stats published by Orthopaedic Institute, Stuart Gold, M.D., Inc., over 600,000 arthroscopy surgeries are performed every year and knee arthroscopy surgery contributes over 80% of the total procedures. Arthroscopic knee surgery is commonly used to treat patella-femoral syndrome.
Major players in the arthroscopy devices market are focusing on introducing various technological advancements in their products. For instance, Vimex Sp. z o.o. - a leading arthroscopy device manufacturing company - provides wireless footswitch to operate the shaver during surgical procedure also the shaver automatically get connect with the handpiece and set of previously used instruments and it has counter-wise and counter-clockwise rotation modes, which help to increase the efficiency of instrument during procedure.
Key takeaways of the market:
• The global arthroscopy devices market is expected to expand at a CAGR of 5.4% during the forecast period (2017-2025). Technological advancements in devices is expected to favor the demand for arthroscopy devices over the forecast period.
• The arthroscopy implants segment in the global arthroscopy devices market was estimated to be the largest in 2016 and is expected to retain its dominance in the market throughout the forecast period in terms of value closely followed by arthroscopy visualization systems. Rise in cases for joint pain and knee surgery globally is projected to support the growth for arthroscopy devices market in the near future.
• The market in North America is expected to expand at a significant CAGR of 4.7% during the forecast period, owing to more installations of arthroscopy devices
• The global arthroscopy devices market is characterized by strategic research and development and advancements in the arthroscopy devices
• Some of the major players in the global arthroscopy devices market are Smith & Nephew, Olympus Inc., Karl Storz, Stryker Corporation, CONMED Corporation, Vimex Sp. z o.o. and DePuy Synthes Inc.
**If you have any special requirements, please let us know and we will offer you the report as you want.
About WMR
Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.
Contact Us:
Mr. Shah
Worldwide Market Reports
1001 4th Ave,
#3200
Seattle, WA 98154,
llU.S
Tel: +1 415 871 0703
Worldwide Market Reports added Latest Research Report titled “Vitamins Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis ”to its Large Report database.
The Global Vitamins Market was valued at US$ 5.16 billion in 2016, according to a new report published by Coherent Market Insights. Vitamins are organic substances that are required by the body in small amounts, for proper growth and development. These are usually extracted naturally from certain food and is an essential component of diet. However, inadequate intake of vitamins in the diet may led to certain deficiency diseases, such as avitaminosis. North America dominated the global vitamins market during the last five years and is expected to retain its dominance in the market throughout the forecast period, due to growing consumer preferences for healthy diet coupled with increasing awareness for various vitamins deficiency diseases. Pharmaceuticals is the largest and the fastest growing segment amassmong end use industry segments for vitamins market. For instance, India Brand Equity Foundation (IBEF)—a Trust established by the Department of Commerce, Ministry of Commerce and Industry, Government of India—the overall Indian healthcare market was valued at US$ 100 billion in 2016 and is expected to grow to US$ 280 billion by 2020, at a Compound Annual Growth Rate (CAGR) of 22.9%. The growing end use industry such as pharmaceuticals, personal care, food & beverages and animal feed is propelling the market for vitamins during the forecast period. Pharmaceuticals followed by animal feed and personal care is dominating the market in 2016 and the trend is expected to remain the same from 2017 to 2025.
Request for Sample Copy of Research Report: https://www.worldwidemarketreports.com/sample/187609
Vitamins are classified into two types, water soluble and fat soluble. Water soluble vitamins (vitamin B-complex group and vitamin C), are easily dissolve in water and can be absorbed by the body. However, these vitamins are not stored in the body and excreted as urine, so a continuous supply is required in our everyday diet. Fat soluble vitamins (A, D, E, K), are dissolved in fat prior to being absorbed into the bloodstream. Excess intake of these vitamins are stored as fats in the liver and fat tissue. According to Coherent Market Insights, the vitamin B, is the dominant segment among product types in the global vitamin market. Whereas, vitamin E is the fastest growing segments in the product type segment and is expected to grow at a CAGR of 5.06% during the forecast period. A vast majority of the global population is at risk of vitamin deficiency related diseases. Various global organizations and governments are continuously focusing on addressing this situation.
Get Best Discount on Research Report: https://www.worldwidemarketreports.com/discount/187609
• On 2012, according to World Health Organization (WHO), an estimated 250 million preschool children are vitamin A deficient and it is likely that in vitamin A deficient areas a substantial proportion of pregnant women is vitamin A deficient. Also, an estimated 250 000 to 500 000 vitamin A-deficient children become blind every year, half of them dying within 12 months of losing their sight.
• UNICEF-supported Vitamin A supplementation programs have been reaching out to children aged 6 to 59 months in priority countries for nearly two decades
Key takeaways of the market:
• Asia-Pacific is projected to be the lucrative region in global vitamins market. It accounted for around 27.6% of overall vitamins market revenue in 2016. The market in this region is expected to be primarily driven by rampant growth of end-use industries in China, India, and ASEAN countries. The growing demand for improved food supplements, rising urbanization, growing economy are some of the key drivers for the growth of vitamins in the Asia-Pacific region.
• The market in Latin America is expected to register a significant growth rate over the forecast period. Rise in discretionary income along with increasing food & beverages industry are expected to create lucrative growth opportunities for the players in this region.
• The mass merchandisers is dominating the market for distribution channel segments in the global vitamins market during the projected period.
• Adisseo France S.A.S., Archer Daniels Midland Co., BASF SE, CSPC Pharmaceuticals Group Limited, Lonza Group Ltd., North China Pharmaceuticals Corporation, Pharmavite LLC, Zhejiang Hangzhou Xinfu Pharmaceutical Co. Ltd. are few of the key players in global vitamins market.
• There are various organic, and inorganic growth strategies which are being followed by the leading market players in the market. Technological advancement is leading to the key innovation in the new product launches. Companies are also investing in expansions, mergers & acquisitions, and joint ventures in the market.
**If you have any special requirements, please let us know and we will offer you the report as you want.
About WMR
Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.
Contact Us:
Mr. Shah
Worldwide Market Reports
1001 4th Ave,
#3200
Seattle, WA 98154,
U.S
Tel: +1 415 871 0703
Worldwide Market Reports added Latest Research Report titled “Personalized Cell Therapy Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis ”to its Large Report database.
The Global Personalized Cell Therapy Market was valued at US$ 3536.2 million in 2016 and is projected to expand at a CAGR of 25.3% during the forecast period (2017-2024 ), as highlighted in a new report published by Coherent Market Insights. The demand for disease specific drugs for treatment of disease that have high prevalence rate, for example autoimmune diseases, diabetes and cancer is expected to support growth of the personalized cell therapy market over the forecast period.
The main process that involved the use of personalized medicine is to get the right treatment for a particular patient depending on the patient's genomics by the help of molecular biomarker tests and targeted therapies. Autoimmune diseases are the leading cause of death, as they are prevalent in almost every age group, though their incidence rate varies with estimates as more than 80 individual type of autoimmune diseases are present such as type I diabetes, rheumatoid arthritis, inflammatory bowel disease and many more. For instance, there were around 20 cases of rheumatoid arthritis per 100,000 person in a year. Although, its prevalence rates range from less than 5 per 100 000 to more than 500 per 100 000.
Request for Sample Copy of Research Report: https://www.worldwidemarketreports.com/sample/187605
The genetic and other predictive information allows the physician to prepare the treatment regime for the specific disease as per patient requirement, also it helps to pin point optimal dosing system, preventing adverse events and focus efforts on prevention and earlier interventions.
There are various approaches involved in the personalized cell therapy that can be effective in oncology, cardiac and other chronic disorders. The approach is often multi-faceted, as it helps in various components during the treatment such as risk assessment, diagnosis, prevention, detection, management and treatment.
Most major players in the personalized cell therapy market are specifically focusing on product development. Thus, the market is currently progressing at a slow pace, though it is expected to gain major traction in the near future, on the backdrop various product being commercialized. As of 2017, there are over 40 cell therapy approved products available in the market. Novartis and Kite Pharma are expected to launch their products in 2017 and commercialize them in the following two to three years. CAR-T cell product launch in 2017 is expected to be catalytic force for overall growth of personalized cell therapy market.
Get Best Discount on Research Report: https://www.worldwidemarketreports.com/discount/187605
Also, there are many drugs in pipeline such as CTL019 (tisagenlecleucel-T), Kte-C19 (axicabtagene ciloleucel) and it is expected that this drugs will drive the global personalized cell therapy market towards positive direction in the near future. Also, according to the University of Nottingham, in 2009, various collaboration between companies took place that were good index of industrial activities and alliances with large companies. There were a total of around 411 cell therapy deals between 1987 and 2008 end. These acquisitions and collaboration throughout the cell therapy sector is expected to support growth of the global personalized cell therapy market, owing to the novel technologies and advancements in the already existing technologies
Key takeaways of the personalized cell therapy market:
• The global personalized cell therapy market is expected to expand at a CAGR of 25.3% duringthe forecast period (2017-2024). Paradigm shift in treatment technologies towards development of drugs is expected to favor growth of the personalized cell therapy market.
• The platelet transfusions application segment in the global personalized cell therapy market was estimated to be the largest in 2016 and is expected to retain its dominance in the market throughout the forecast period in terms of value
• In terms of therapeutic area segment, the cancer treatment area is estimated to be the largest segment as in this are the unmet needs are high and continuous drug development are underway in this disease area.
• The global personalized cell therapy market is characterized by market expansion in Asia Pacific, Latin America, and Middle East could generate higher market revenue as this market is expected to lucrative market for industry players, also various studies that are being done in different countries of Latin America such as Brazil and Mexico to develop drugs based on personalized cell therapy
• Some of the major companies in the global personalized cell therapy market are Cytori Therapeutics Inc., Bellicum Pharmaceuticals, Inc., Saneron CCEL Therapeutics, Inc., M olMed S.p.A. and Vericel Corporation.
**If you have any special requirements, please let us know and we will offer you the report as you want.
About WMR
Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.
Contact Us:
Mr. Shah
Worldwide Market Reports
1001 4th Ave,
#3200
Seattle, WA 98154,
U.S
Tel: +1 415 871 0703
Worldwide Market Reports added Latest Research Report titled “Polyethylene Terephthalate Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis ”to its Large Report database.
The Global Polyethylene Terephthalate Market was valued at US$ 26.57 billion in 2016, according to a new report published by Coherent Market Insights. The increasing demand for bottled water and carbonated soft drinks are expected to dominate the market for PET during 2017-2025. PET bottles are gaining traction in food & beverages industry, due to its light weight, easy to handle, non-breakable and can be recycled into various products such as rain coats, door panel, fibers, industrial strapping among others. Favorable government regulations in Asia Pacific is expected to boost the market for PET during 2017-2025. For instance, in 2015, the Government of India allowed use of PET for pharmaceuticals packaging under Drugs & Cosmetics Act (1940), Schedule M, and Section 16.10. Major players in the market focus on new product development and integrating new technologies in existing product portfolio to meet rising demand of its customer base. For instance, in 2014, SIDEL introduced NEW RIGHTWEIGHT 0.5 liter bottle for still water weighs just 7.95 grams, yet offers a superior consumer experience and a top-load performance of 33 kilograms, without the need for nitrogen dosing, using standard 26/22 closures.
Request for Sample Copy of Research Report: https://www.worldwidemarketreports.com/sample/187601
Petroleum derivatives are used as the primary feedstock in the manufacture of polyethylene terephthalate. Growing demand for PET packaging material from various food & beverages industries, is in turn propel the demand for PET. However, volatility of crude oil prices and growing GHG emission concerns has compelled the manufacturer to shift in focus towards bio based PET product, which in turn is expected to be the key challenges for petroleum based PET. Market leading food & beverages industry are continuously investing to develop environment friendly and bio based packaging material for food & beverages. For instance, in June 2012, The Coca Cola Company, Heinz & Co., Ford Motors, Nike Co. and Proctor & Gamble have signed Plant PET Technology Collaborative (PTC), intended for development and use of 100% bio-based PET in their product offerings. This development in bio based PET is expected to boost the market for PET during the forecast period.Get Best Discount on Research Report: https://www.worldwidemarketreports.com/discount/187601
Key takeaways of the market:
• Asia-Pacific is projected to be the largest region in global polyethylene terephthalate market. It accounted for around 59.8% of overall polyethylene terephthalate market revenue in 2016. The market in this region is expected to be primarily driven by rampant growth of end-use industries in China, India, and ASEAN countries. The growing food & beverages industries, rising economy, growing per capita income of middle class people are some of the key drivers for the growth of polyethylene terephthalate in the Asia-Pacific region.
• The market in Latin America is expected to register a significant growth rate over the forecast period. Rise in discretionary income along with increasing ready to eat food are expected to create lucrative growth opportunities for the players in this region.
• Automotive industry is one of the key industries for the use of polyethylene terephthalate. A strong automobile sales in Asia-Pacific and Europe is expected to enhance the growth of polyethylene terephthalate in the forecast period. The automotive applications such as headlamp retainer, wiper arm and gear housings, engine cover, connector housings are the key automotive application for the use of polyethylene terephthalate. According to India Brand Equity Foundation (IBEF), is a Trust established by the Department of Commerce, Ministry of Commerce and Industry, Government of India, South Korea's Kia Motors Corp is close to finalizing a site for its first factory in India, slated to attract US$1 billion (Rs 6,700 crore) of investment. It is deciding between Andhra Pradesh and Maharashtra. The target for operationalizing the factory is the end of 2018 or early 2019.
• Alpek S.A.B de C.V., RTP company, BASF SE, The Dow Chemicals Company, Jiangsu Sanfangxiang Group, Indorama Ventures, M&G Chemicals, Nan Ya Plastics Corporation, Far Eastern New Century and Quadrant AG. are few of the key players in global Polyethylene Terephthalate market.
• There are various organic, and inorganic growth strategies which are being followed by the leading market players in the market. Technological advancement is leading to the key innovation in the new product launches. Companies are also investing in expansions, mergers & acquisitions, and joint ventures in the market.
**If you have any special requirements, please let us know and we will offer you the report as you want.
About WMR
Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.
Contact Us:
Mr. Shah
Worldwide Market Reports
1001 4th Ave,
#3200
Seattle, WA 98154,
U.S
Tel: +1 415 871 0703
Worldwide Market Reports added Latest Research Report titled “Ethylene Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis ”to its Large Report database.
The Global Ethylene Market was estimated at US$ 121.07 Billion and 146.6 million metric tons in 2016, according to a new report published by Coherent Market Insights. Ethylene is a colorless, flammable gas with sweet and musky odor, having molecular formula C2H4. Ethylene is widely used in the manufacturing of various derivative such as polyethylene, ethylene oxide, ethylene dichloride and others. Ethylene is also used in agriculture industry as a natural plant hormone, which helps in ripening of fruits. Manufacturing industry uses various processes in the manufacture of ethylene, which includes, steam cracking of hydrocarbons followed by compression and distillation. There are various feedstocks which are used in the production of ethylene includes naphtha, ethane, butane, propane, coal, and others (Methanol to olefins (MTO), gasoil).
Ethylene is mainly used in the production of polyethylene, which finds wide applications in packaging industry, automobiles, construction and manufacturing units. These are mainly attributed due to its high tensile strength, resistance to chemicals and heat.
Request for Sample Copy of Research Report: https://www.worldwidemarketreports.com/sample/187597
Key Feedstock Trends and Analysis of the Ethylene market:
• Naphtha feedstock segment dominated the ethylene market in 2016, according to the stats provided by Coherent Market Insights. Naphtha is the largest feedstock used in the Asia-Pacific, and Western Europe regions. Ethane is the dominant feedstock used in North America, and Middle East regions. The production cost of ethylene is comparatively low with ethane as a feedstock compared to naphtha.
• In North America, the boom in exploiting shale gas reserves has led in producing low cost ethane gas, hence lowering the production cost of ethylene to 60% on comparing with naphtha as a feedstock. Furthermore, the boom in exploiting shale gas reserves for the production of ethane in North America has led to a lot of capacity expansions in ethylene plants. The region has witnessed over 2 million MT/Year of ethylene capacity addition during the past four years and over 620,000 MT/ year ethylene production is expected to add by 2017.
• Saudi Arabia being one of the largest producer of oil and gas in Middle East region is able to produce ethylene in just approximately US$ 50 per metric ton with ethane as a feedstock, which in turn is leading to the high capacity addition in the region. The Gulf Cooperation Council (GCC) countries contributed 11% of global petrochemical-capacity growth over the past ten years and are now a leading global producer and supplier to world markets of ethylene and its derivatives. There are many projects which are under construction or at the planning stage in Saudi Arabia, Kuwait, Abu Dhabi, and Oman would be able to add a further 34 million tons of annual capacity over the following years, which in turn will increase the GCC's share of global ethylene production from 18% to 21% by 2025.
• The regions such as Middle East, and North America are also using propane, butane and MTO as a feedstock to produce ethylene at a low cost on comparing with naphtha. Currently, North America and Middle East are the dominant regions for consuming propane and butane as a feedstock for producing ethylene in much lower cost than naphtha.
Get Best Discount on Research Report: https://www.worldwidemarketreports.com/discount/187597
• In Asia-Pacific, China is the largest coal consuming country in developing energy has started using coal and MTO as a feedstock to produce ethylene from its coal to olefins (CTO) and methanol to olefins (MTO) plants. This has lowered the cost of producing ethylene at a much higher rate in the country, which in turn has led to lot of capacity expansions of ethylene in China. Furthermore, the ethylene capacity in India for fiscal year 2016-17 is projected at 4.8 MMT which includes Reliance J3 expansion as well as ONGC Petro additions Limited (OPAL) having commissioned its mega petrochemical complex at Dahej. The total ethylene capacity in India is projected to be 7.2 MMT during fiscal year 2017-18.
• Hence, the feedstock cost trends are largely driving consumption growth between geographic regions. The growing consumption of ethane, propane, butane and coal for the low cost of production of ethylene is the major factor for the robust growth in the ethylene market during the forecast period.
Key takeaways of the market:
• Asia Pacific is expected to dominate the market in 2016 and the trend is expected to remain the same during 2017-2025. The increasing demand of ethylene derivatives in various end-use industries such as packaging, automobile, and construction industry, and continuous capacity addition of ethylene in China and India over following years are the major driving force to position Asia-Pacific as the largest and fastest-growing region in the global ethylene market. Moreover, North America is expected to experience a second highest CAGR of 5.6% in terms of volume, during the forecast period. This is due to the shale gas boom in the country is leading to the huge growth in the natural gas production which in turn is allowing North America for the huge capacity addition in the following years.
• The market in Middle East is expected to register a significant growth rate over the forecast period. Capacity addition coupled with cheap raw material price are expected to create lucrative growth opportunities for the market in this region. For instance, Sadara Chemical Company announced to increase their ethylene production capacity by 1500 thousand metric tons per year in Saudi Arabia.
• Polyethylene industry is one of the key industries for the use of Ethylene. Polyethylene are widely used in the manufacture of high density polyethylene (HDPE), low density polyethylene (LDPE), linear low density polyethylene (LLDPE), crosslinked polyethylene (PEX), and many more which finds wide applications in various food & non-food packaging, shrink & elastic films, extruded pipes, and molding. For instance, The Dow Chemical Company has a 250,000 MT/year polyethylene expansion at its Louisiana Operations complex in Plaquemine set for completion by end-2017, is expected to boost the market for polyethylene, which in turn is driving the ethylene market during the forecast period. Also, in 2016, Gail India Ltd. has commissioned a new processing line for polyethylene at its Pata petrochemical facility in Uttar Pradesh (UP) increasing its PE capacity by 400,000 tonnes per annum (TPA).
• Saudi Basic Industries Corporation (SABIC), Exxon Mobil Corporation, The Dow Chemical Company, Royal Dutch Shell plc, China Petroleum & Chemical Corporation (Sinopec Corporation), Chevron Phillips Chemical Company LLC, Total S.A., LyondellBasell Industries, National Petrochemical Company (NPC), and INEOS Group AG, and others are few of the key players in global ethylene market.
• There are various organic, and inorganic growth strategies which are being followed by the leading market players in the market. Capacity expansion is leading to the key driver in the acquisition and joint ventures. For instance, Mexichem had signed a 50/50% co-investment agreement with OxyChem to build a 550 thousand ton annual capacity ethylene cracker, investing close to US$1.5 billion, and is expected to start operation in 2017. Also, there are lot of capacity expansions is been done in Asia-Pacific region from both domestic and international market players includes Jiangsu Sailboat (China - 320 thousand tons per year), KPIC (Korea - 330 thousand tons per year), Shenhua Ningmei (China - 430 thousand tons per year), Changzhou Fund (China - 130 thousand tons per year), Zhongtian Hechuang No2 (China - 300 thousand tons per year), Reliance Jamnagar (India - 1,365 thousand tons per year), CNOOC Shell (China - 1000 thousand tons per year), Lotte Titan (Malaysia - 92 thousand tons per year), and Shaanxi Yanchang (China - 300 thousand tons per year).
**If you have any special requirements, please let us know and we will offer you the report as you want.
About WMR
Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.
Contact Us:
Mr. Shah
Worldwide Market Reports
1001 4th Ave,
#3200
Seattle, WA 98154,
U.S
Tel: +1 415 871 0703
Email: sales@worldwidemarketreports.com
Worldwide Market Reports added Latest Research Report titled “Shotcrete Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis ”to its Large Report database.
The Global Shotcrete Market was valued at US$ 5.61 billion in 2016, according to a new report published by Coherent Market Insights. Shotcrete is a technique used to spray concrete through a hose at high velocity onto surface pneumatically. The concrete mixed with water are sprayed through a nozzle over the substrate. Growing population and propelling economy of Asia Pacific leads to infrastructure development and sustainable public transport. Rapid investment in underground tunneling and metro rail construction to avoid traffic and reduce travelling time in densely populated region of Asia Pacific is expected to lead to exponential growth of the market for shotcrete during 2017-2025. Moreover, technological advancements in shotcrete, would further increase its application area during the forecast period. For instance, Shot-Tech robotic system deploys a remote-controlled spraying arm for underground and tunneling construction purposes. Putzmeister Shotcrete Technology is leading the industry for design and manufacture of wet- and dry-process shotcrete equipment.
Request for Sample Copy of Research Report: https://www.worldwidemarketreports.com/sample/187593
The global shotcrete market was dominated by Europe in 2016, due to continuous development in public transportation systems which includes, underground metro rail and tunnels. Moreover, wet-mix shotcrete is expected to replace conventional concrete in underground construction, due to its various. Also, the market in North America is expected to witness significant growth during the forecast period, mainly due to increasing infrastructure development activities underway and inline in the near future. For instance, New York East Side Access worth over US$ 10 billion, Honolulu Rail Transit project worth over US$ 6 billion, Toronto's Eglinton Crosstown light rail project worth over US$ 5 billion, Los Angeles' Purple Line Extension Phase-1 project worth over US$ 2.8 billion, Seattle's East Link Light Rail project worth over US$ 2.8 billion and Washington's Silver Line Phase-2 project worth over US$ 2.8 billion are expected to propel the market for shotcrete form 2017-2025.
Get Best Discount on Research Report: https://www.worldwidemarketreports.com/discount/187593
Key takeaways of the market:
• Asia-Pacific is projected to be the fastest growing region in global Shotcrete market. It accounted a CAGR of 9.3% from 2017-2025 in terms of revenue. The market in this region is expected to be primarily driven by rampant growth of tunnels, water retaining structures in China, India, and ASEAN countries. The growing need of underground metro lines and tunnels, rising urbanization and growing demand for reliable public transport are some of the key drivers for the growth of Shotcrete in the Asia-Pacific region.
• The market in Latin America is expected to register a significant growth rate over the forecast period. Rise in construction activities are expected to create lucrative growth opportunities for the players in this region.
• Mining companies, engineers and contractors are increasingly deploying quick, reliable, economic and efficient technology of pneumatically operated shotcrete. Shot-tech robotic system technology is dominating the market for shotcrete as it enables the shotcrete to spray automatically after blasting and allowing the nozzle operating crew to be safe.
• BASF SE, Heidelberg Cement, Grupo ACS, Lafargeholcim, Cemex, Sika AG, GCP Applied Technologies, U.S. Concrete, Mapei, and Normet are among the key players in global shotcrete market
• Technological advancement is leading to the key innovation in the new product launches. Companies are also investing in expansions, mergers & acquisitions, and joint ventures in the market. The key multinational players rapidly investing in shotcrete technology to fulfil the growing demand for shotcrete in Europe and Asia Pacific. For instance, BASF AG installed a shotcrete plant in Andhra Pradesh, India. Moreover Sika AG started a shotcrete plant in Australia, to meet the growing demand for shotcrete in rail tunnels, suburbs in Forrest field Airport link.
**If you have any special requirements, please let us know and we will offer you the report as you want.
About WMR
Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.
Contact Us:
Mr. Shah
Worldwide Market Reports
1001 4th Ave,
#3200
Seattle, WA 98154,
U.S
Tel: +1 415 871 0703
Worldwide Market Reports added Latest Research Report titled “Contraceptives Drugs And Devices Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis ”to its Large Report database.
The Global Contraceptive Drugs and Devices Market was valued at US$ 18,273.2 million in 2015 and is projected to expand at a CAGR of 7.8% during the forecast period (2016-2024), as highlighted in a new report published by Coherent Market Insights. Better accessibility to contraceptives and growing awareness among the populace about the various benefits and ease of use of such contraceptive is contributing towards the growth of contraceptives drugs and devices market.
Preference of contraceptive methods greatly varies by region. For instance, of the overall contraceptives available, the use of oral contraceptive pills is higher in Europe, while the use of IUD was higher in Asia. High rate of sterilization (15 yrs-49 yrs) in North America (33%), Asia and Latin America is limiting the growth of contraceptive drugs and devices. Sterilization is the preferred method of contraception in India, while condoms are in the preferred choice in Japan according to the study by the United Nations in 2015. Change in demographics is driving a shift in the demand for contraceptive methods, especially in the European region where there is a paradigm shift in the demand from tampons to coil, implant or progestin only pill that non-regularizes the menstrual cycle.
In the U.S., contraceptives are covered under the commercial health insurance policies through Affordable Care Act (ACA). This has significantly reduced out-of-pocket expenses on oral contraceptive pills from 21.8% in 2011 to 3.6% in 2014. The newly formed Trump government has stated to ensure the coverage of contraceptives and all essential abortion related services without any co-pays, co-insurance or deductibles.
Request for Sample Copy of Research Report: https://www.worldwidemarketreports.com/sample/187589
The U.S. FDA approved Liletta, a hormonal IUD, in 2015. Liletta was already being marketed in the Europe before being approved in the U.S. The product is marketed in collaboration between the manufacturers - Allergan Plc and Medicines 360. The product is also promoted by Women's Health Alliance, an organization engaged in promoting high-quality affordable healthcare for women, making it affordable or even free to low income women groups.
Plethora of products are available for female contraception compared to male contraception. Research is underway to develop and commercialize male contraceptive products. Vasalgel—a long acting non-hormonal contraceptive—is one such male contraceptive product in the research phase, funded by the Parsemus Foundation, which works to advance the innovative but neglected medical research. Vasalgel demonstrated successful results in pre-clinical studies and is expected to enter clinical trials in the near future.
Reversible Inhibition of Sperm Under Guidance (RISUG) is another male contraceptive product under development and is currently in the phase 3 study in India. RISUG, invented by Prof. Sujoy K. Guha, Indian Institute of Technology (IIT), involves blocking the vas deferens with a gel that can be flushed out when contraception is no longer needed. Launch of new effective products is expected to benefit the global contraceptive drugs and devices market.
Get Best Discount on Research Report: https://www.worldwidemarketreports.com/discount/187589
Preference of contraceptive methods greatly varies by region. For instance, of the overall contraceptives available, the use of oral contraceptive pills is higher in Europe, while the use of IUD was higher in Asia. High rate of sterilization (15 yrs-49 yrs) in North America (33%), Asia and Latin America is limiting the growth of contraceptive drugs and devices. Sterilization is the preferred method of contraception in India, while condoms are in the preferred choice in Japan according to the study by the United Nations in 2015. Change in demographics is driving a shift in the demand for contraceptive methods, especially in the European region where there is a paradigm shift in the demand from tampons to coil, implant or progestin only pill that non-regularizes the menstrual cycle.
In the U.S., contraceptives are covered under the commercial health insurance policies through Affordable Care Act (ACA). This has significantly reduced out-of-pocket expenses on oral contraceptive pills from 21.8% in 2011 to 3.6% in 2014. The newly formed Trump government has stated to ensure the coverage of contraceptives and all essential abortion related services without any co-pays, co-insurance or deductibles.
The U.S. FDA approved Liletta, a hormonal IUD, in 2015. Liletta was already being marketed in the Europe before being approved in the U.S. The product is marketed in collaboration between the manufacturers - Allergan Plc and Medicines 360. The product is also promoted by Women's Health Alliance, an organization engaged in promoting high-quality affordable healthcare for women, making it affordable or even free to low income women groups.
Plethora of products are available for female contraception compared to male contraception. Research is underway to develop and commercialize male contraceptive products. Vasalgel—a long acting non-hormonal contraceptive—is one such male contraceptive product in the research phase, funded by the Parsemus Foundation, which works to advance the innovative but neglected medical research. Vasalgel demonstrated successful results in pre-clinical studies and is expected to enter clinical trials in the near future.
Reversible Inhibition of Sperm Under Guidance (RISUG) is another male contraceptive product under development and is currently in the phase 3 study in India. RISUG, invented by Prof. Sujoy K. Guha, Indian Institute of Technology (IIT), involves blocking the vas deferens with a gel that can be flushed out when contraception is no longer needed. Launch of new effective products is expected to benefit the global contraceptive drugs and devices market.
Around 15 million of the 16.7 million unwanted pregnancies could be averted in 35 low and middle income countries on using the modern contraceptive methods by women, according to finding of a study published by the World Health Organization (WHO) in 2015. Various philanthropist and social organizations associated with them are proactively working towards reducing such instances of unplanned pregnancies. The global partnership program called the Family Planning 2020, led by Melinda Gates, is committed to provide easy access to contraceptive to 120 million women across the globe by 2020. Such global initiatives are contributing significantly to the bulk revenues in the contraceptive drugs and devices market.
Key takeaways of the market:
• The contraceptive drugs and devices market is dominated by North America, followed by Europe in terms of value. With more patent expirations expected in the near future, the market of oral contraceptive pills, injectables and IUDs is projected to be flushed with generics, especially in the oral pills market.
• Contraceptive pills is the most preferred contraception method except in the Asian region, where IUD leads the market.
• Launch of Twirla, a contraceptive patch, would be a threat for oral pills owing to convenience of drug administration through transdermal route
• Based on the number of potential users of contraceptives globally, there is still a huge untapped market which market players need to address through creating awareness and increasing market access
• Products are extensively promoted through social media by manufacturers to directly connect with the users. Market penetration will generate targeted return on investments on promotion in the global contraceptive drugs and devices market
• The availability of contraceptive drugs and devices through online channels, essentially in the developed regions, has eased the purchase and increased reach of contraceptive products.
**If you have any special requirements, please let us know and we will offer you the report as you want.
About WMR
Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.
Contact Us:
Mr. Shah
Worldwide Market Reports
1001 4th Ave,
#3200
Seattle, WA 98154,
U.S
Tel: +1 415 871 0703